Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01009086 · ClinicalTrials.gov registry record · Phase 3

A Study of the Safety and Effectiveness of Ustekinumab in Patients With Psoriatic Arthritis

A Phase 3 study of Arthritis, Psoriatic, sponsored by Janssen Research & Development.

Completed
Registry status
Phase 3
Development phase
615
Enrollment target
20
Study locations

NCT01009086 is a Phase 3 study of Arthritis, Psoriatic that has completed, run by Janssen Research & Development. The registered enrollment target is 615 participants, above the 538-participant average among 16 other Arthritis, Psoriatic trials with a reported enrollment target (14% higher). The trial reports 20 study locations across 15 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01009086, a Phase 3 study of Arthritis, Psoriatic, has completed, sponsored by Janssen Research & Development.

COMPLETED
Registry status
Phase 3
Development phase
615 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to evaluate the effectiveness (improvement of signs and symptoms) and safety of ustekinumab in participants with active psoriatic arthritis.

Conditions Studied

Arthritis, Psoriatic

Interventions

  • DRUG Placebo
  • DRUG Ustekinumab 45 mg
  • DRUG Ustekinumab 90 mg

Study Locations (20)

California

  • - Encinitas
  • - La Jolla
  • - San Diego

Massachusetts

  • - Boston
  • - Fall River
  • - Worcester

Oklahoma

  • - Norman
  • - Tulsa

Colorado

  • - Denver

Connecticut

  • - Trumbull

Florida

  • - Tampa

Illinois

  • - Chicago

Indiana

  • - Indianapolis

Trial Details

FieldValue
Enrollment Target 615 participants
Start Date 2009-12
Est. Completion 2013-05
Phase Phase 3

Sponsor

Janssen Research & Development

593 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01009086

The ClinicalTrials.gov registry entry for NCT01009086 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 615 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 538-participant average among 16 other Arthritis, Psoriatic trials with a reported enrollment target (14% higher). The listed sponsor is Janssen Research & Development, which has 593 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Arthritis, Psoriatic appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT01009086 reports 20 study locations spanning 15 distinct geographic areas - top geographies include California, Massachusetts, Oklahoma.

Frequently Asked Questions

What is clinical trial NCT01009086 about?

NCT01009086 is a clinical study titled "A Study of the Safety and Effectiveness of Ustekinumab in Patients With Psoriatic Arthritis". The purpose of this study is to evaluate the effectiveness (improvement of signs and symptoms) and safety of ustekinumab in participants with active psoriatic arthritis.

What is the current status of trial NCT01009086?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 615 participants. The study started on 2009-12. Estimated completion is 2013-05.

What conditions does trial NCT01009086 study?

This clinical trial studies the following conditions: Arthritis, Psoriatic.

What interventions are being tested in trial NCT01009086?

The interventions under investigation include: Placebo (DRUG), Ustekinumab 45 mg (DRUG), Ustekinumab 90 mg (DRUG).

Who is sponsoring clinical trial NCT01009086?

This trial is sponsored by Janssen Research & Development, which has 593 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01009086 being conducted?

This trial has 20 study locations across California, Colorado, Connecticut, Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Arthritis, Psoriatic

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Arthritis, Psoriatic

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.